account_balance
Investment manager · 13F filer · SEC CIK 1854794
Patient Capital Management, LLC
Reported value$3.01Bas of Jun 30, 2026
Positions39 2 new, 1 sold out
Top 10 weight52.1%RPRX alone is 7%
FiledAug 1344 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
RPRXRoyalty Pharma PLC
6.7%
CCitigroup Inc
6.5%
GOOGLAlphabet Inc
6.2%
UNHUnitedhealth Group Inc
6.0%
AMZNAmazon Com Inc
5.4%Added +4%
NVDANvidia Corporation
4.7%
CVSCVS Health Corp
4.2%Trimmed −9%
NCLHNorwegian Cruise Line Hldgs
4.2%Added +5%
QXOQxo Inc
4.1%Added +5%
ETEnergy Transfer L P
3.9%
PPLIPeople Inc
3.7%Trimmed −10%
PGEN3.6%RPRX6.7%C6.5%GOOGL6.2%
UNHUnitedhealth Group Inc
6.0%
AMZNAmazon Com Inc
5.4%Added +4%
NVDANvidia Corporation
4.7%
CVS4.2%NCLH4.2%QXO4.1%ET3.9%PPLI3.7%PGEN3.6%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
RPRX Royalty Pharma PLC 6.7% HeldC Citigroup Inc 6.5% HeldGOOGL Alphabet Inc 6.2% HeldUNH Unitedhealth Group Inc 6.0% HeldAMZN Amazon Com Inc 5.4% Added +4%NVDA Nvidia Corporation 4.7% HeldCVS CVS Health Corp 4.2% Trimmed −9%NCLH Norwegian Cruise Line Hldgs 4.2% Added +5%QXO Qxo Inc 4.1% Added +5%ET Energy Transfer L P 3.9% HeldPPLI People Inc 3.7% Trimmed −10%PGEN Precigen Inc 3.6% Added +7%
What changed